Medical Devices

Develop Institutional Following & IR Infrastructure

This micro-cap medical devices company’s shareholder base largely consisted of retail investors, with little or no institutional ownership. There was no investor relations framework of quarterly conference calls, analyst coverage or regular press releases.

Strategy & Tactics
  • We developed an institutional following so that as the company rolled out its new growth product, it would have an audience that would recognize the progress it was making, and so be attracted to buying the stock.
  • An investor relations infrastructure was implemented, including the development of investor relations materials and practices to ensure regular communication with the market.
  • We introduced management to 17 small cap and microcap investors in the first year of working with the company, two of whom subsequently took positions.
  • We introduced management to 7 sell-side analysts covering medical devices, two of whom initiated coverage.
  • Management was introduced to 6 healthcare-focused investors.
  • Invitations for management to attend investor conferences were secured, including conferences focused on microcaps and healthcare.
  • We ensured a consistent flow of news to the markets, covering areas including quarterly earnings, new hires, product development and regular updates.